Orthopedic surgeon Brian Grawe, MD, said he's optimistic about the trajectory of artificial intelligence in medicine.
Dr. Grawe, of the University of Cincinnati, shared his insights on AI and the research he's excited about.
Note: Responses were lightly edited for clarity.
Q: What are you most proud of from the last year?
Dr. Brian Grawe: This past year the University of Cincinnati and I have launched a multi-center study investigating the effects of a novel treatment option for the augmentation of meniscal repairs. Through bench-top research we have been able to demonstrate the positive effects of adding 'simvastatin' to the repair construct. The safe, low cost and readily available cholesterol drug can modulate BMP-2 synthesis and thus promote chondrogenesis. The multi-center study is being funded by the Department of Defense with a budget of $1.9 million.
Q: What are the biggest trends you're following in healthcare right now?
BG: The biggest trend in orthopedics right now is the arms race that is artificial intelligence. This arms race includes better, more efficient delivery of patient care, as well as decreasing the cost burden of medical care. I believe that harnessing the power of AI will allow surgeons to better meet the expectations of their patients, more effectively communicate about the point of care options, and ultimately maximize the work flow of getting patients in the door and out the door. We are at the tip of the iceberg and the ceiling is high.
Q: What are you excited about for 2024?
BG: I am most excited about the rapidly evolving ways surgeons can now share. The advent of virtual meetings and virtual reality simulation/learning is something that is truly wonderful. Surgeons are going to begin to be able to exponentially leverage their own expertise to help take care of difficult pathologies.